Two months ago, a study in JAMA Internal Medicine indicated that radioactive iodine, a decades-old pill used to treat hyperthyroidism, may be linked to cancer. But in a highly unusual twist, two of the co-authors subsequently published commentary in a different journal, citing data that was omitted from the JAMA Internal Medicine study to suggest any cancer risk was minimal — and that anti-thyroid medicines may actually have a significantly higher risk of causing cancer.

Now, the National Cancer Institute, which funded the JAMA Internal Medicine study and claims the pair did not have permission to use what it called preliminary data, asked the other journal, Clinical Nuclear Medicine, for a retraction, according to its editor. The NCI, however, denied seeking a retraction. Meanwhile, one of the two dissenting authors has since had a change of heart and wants the commentary retracted.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy